Verve Therapeutics Inc’s filing revealed that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on Apr
Verve Therapeutics Inc’s recent filing unveils that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on
Verve Therapeutics Inc’s filing revealed that its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on Apr
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
In a filing, Verve Therapeutics Inc revealed its Chief Executive Officer Kathiresan Sekar unloaded Company’s shares for reported $40761.0 on
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Verve Therapeutics Inc. (NASDAQ:VERV) does about 768.12K shares in volume on a normal day but saw 618802 shares change hands